£2 million of new MS research
Published date: 11 Oct 2016 at 8:36AM
We’re proud to announce that 11 new projects have secured funding through our 2016 grant round.
From investigating if a stroke drug could repair damage caused in MS to testing the benefits of specialist rehab, these projects cover a wide range of topics.
Managing MS symptoms and developing services are the focus for three projects. The other eight are biomedical. Those aim to understand more about the causes of MS – and discover targets for developing new treatments.
We’ve committed to raising £1,955,578 to support these cutting-edge research projects, which will all be starting in the next few months.
How did we decide?
Projects we fund need to be
- of an international standard
- focused on answering questions important to people living with MS.
Experts and people with MS review all the applications. This year we had 56 applications, which made for some very difficult decisions.
Read more about each project:
Understanding the cause of MS
- What is the role of antibodies in chronic inflammation in MS?
- Can cerebrospinal KIF levels predict MS progression?
- Can blood metabolomics predict the course of MS?
Developing new treatments
- Do microglia immune cells produce useful targets for myelin repair?
- Could modified heparin promote myelin repair?
- Can Gas6 help repair myelin in MS?
- Does fractalkine coordinate myelin repair in MS?
- Is TSPO a good target for neuroprotection?
Care and services
- Is specialist rehabilitation economically as well as socially beneficial?
- What factors affect quality of life for people with MS?
- Can iSTEP-MS help people with MS to increase their physical activity?